Related by context. All words. (Click for frequent words.) 80 XL# anticancer compounds 76 oral prodrug 76 virus HCV protease inhibitor 76 VEGFR2 inhibitor 75 non nucleoside inhibitor 75 AAG geldanamycin analog 75 HCV polymerase inhibitors 75 TKB# 75 dasatinib Sprycel ® 74 PEGylated Fab fragment 74 Crofelemer budesonide foam 74 evaluating picoplatin 74 orally administered inhibitor 74 pralatrexate injection folate analogue 74 Initiates Phase II 74 developing Bicifadine serotonin 74 PNP inhibitor 74 PRN FDA Approves 74 oral proteasome inhibitor 74 Ovitrelle R Serostim 73 Albuferon TM 73 phenylketonuria PKU developed 73 pan histone deacetylase 73 prokinetic agent 73 MKC# MT 73 lintuzumab SGN 73 dimebon latrepirdine 73 erlotinib Tarceva ® 73 nilotinib Tasigna ® 73 Meets Primary Endpoint 73 TRIOLEX HE# APOPTONE HE# 73 AKT inhibitor 73 topical gel formulation 73 dihydrochloride Tablets 73 CD# CEA 73 2 methoxyestradiol 72 R roscovitine CDK cyclin 72 NU# direct 72 Completes Patient Enrollment 72 familial amyloidotic polyneuropathy FAP 72 Epothilone D 72 CYT# potent vascular disrupting 72 HGS ETR1 mapatumumab 72 IMiDs ® 72 sapropterin dihydrochloride 72 dependent kinase inhibitor 72 cancer indications bafetinib 72 LymphoStat B belimumab 72 class anticancer quinolone 72 ALN PCS 72 methylnaltrexone bromide 72 Budesonide foam crofelemer 72 R Saizen R 72 Completes Enrollment 72 MCSP respectively 72 novel VDA molecule 72 IMPDH inhibitor 72 MEK Inhibitor 72 Initiates Enrollment 72 ALN HPN 72 Initiates Phase 72 CD4 monoclonal antibody 72 recurrent metastatic ovarian cancer 72 agonistic human 72 vascular occlusive diseases 72 Pruvel TM 72 R MSCRAMM 72 Submits Biologics License Application 72 Frozen Shoulder syndrome Adhesive 72 oropharyngeal candidiasis OPC 72 MKC# MKC# PP 72 candidates Azedra TM 72 including eniluracil ADH 72 antiangiogenesis therapies 72 refractory chronic lymphocytic 72 Empatic ™ 71 Vitrasert R 71 Mg Usa 71 Phase 2b Clinical Trial 71 Mg Uk 71 CDK cyclin dependent 71 active AKT inhibitor 71 Investigational Oral 71 TRIOLEX ™ 71 mGluR5 negative 71 LymphoStat B TM 71 oral ghrelin agonist 71 particularly SANCTURA XR 71 R rilonacept Injection 71 Pharma Merck Serono 71 transthyretin mediated amyloidosis ATTR 71 MKC# 71 metabolic disorders Saizen R 71 XL# XL# 71 forodesine purine nucleoside phosphorylase 71 aldehyde dehydrogenase ALDH2 deficiency 71 Phase IIb Trial 71 Initiates Phase III 71 Begins Dosing 71 acetonide FA 71 somatropin Kuvan R 71 drug pipeline TAFA# 71 candidate XP# 71 novel orally inhaled 71 Amigal TM 71 Initiate Phase 71 brand ciclesonide HFA 71 oncolytic virus therapies 71 topically applied SEPA 71 Panzem R 71 Atripla combines 71 overactive bladder VANTAS R 71 influenza BCX# purine nucleoside 71 small molecule thrombopoietin 71 Zorbtive TM 71 albiglutide 71 personalized cellular immunotherapy 71 HCV NS5B polymerase 71 TO AVOID PREGNANCY WHILE 71 nucleoside analog 71 6 sulfatase 71 FOLFOX6 chemotherapy regimen 70 cutaneous T 70 Telik logo TELINTRA 70 ocular formulation 70 topical antifungal product 70 delta gamma agonist 70 Receives Orphan Drug Designation 70 FEMALES SHOULD BE ADVISED 70 Luramist TM 70 Diovan Exforge Tekturna Zelnorm 70 XL# XL# XL# XL# 70 Pruvel ™ 70 Lenocta TM 70 TRANSDUR ® 70 cetuximab Erbitux R 70 Testosterone MDTS R 70 non constipating irritable 70 metaglidasen 70 modified glutathione analog 70 kidney urologic 70 Merck OSI Pharmaceuticals 70 GVAX ® 70 Dementia Related Psychosis 70 trastuzumab Herceptin R 70 Luveris R Ovidrel R 70 Annamycin 70 markets COLAZAL 70 5 HT3 antagonist 70 products MKC# PP 70 diarrhea predominant irritable 70 Mylan Receives Approval 70 delivers fluocinolone acetonide FA 70 neuropathic pain metabolic diseases 70 relapsed leukemia 70 novel emulsion formulation 70 recombinant PSMA vaccine 70 targeted radiotherapeutic 70 inflammatory autoimmune diseases 70 Complicated Skin 70 IV FENTORA R 70 Presents Preclinical Data 70 Serostim ® 70 combines bupropion 70 sapacitabine CYC# 70 catheter occlusion 70 Retisert R 70 approved incretin mimetic 70 Fovea Pharmaceuticals subsidiary 70 4SC AG ISIN DE# 70 rusalatide acetate 70 polymerase inhibitor 70 BCG refractory carcinoma 70 Warner Chilcott Actonel 70 sanofi aventis Bayer Schering 70 sodium glucose cotransporter 70 P#X# antagonist 70 sodium thiosulfate STS 70 vitreoretinal disorders 70 interferon beta 1a infertility 70 candidate deforolimus 70 Solazed TM 70 chronic eosinophilic leukemia 70 lexidronam injection 70 Cloretazine ® 70 5 fluorouracil leucovorin 69 Tezampanel 69 Pharmacokinetics PK 69 DEB# 69 Presents Positive 69 RAS MAPK pathway 69 formerly LymphoStat B 69 essential thrombocythemia ET 69 delta opioid receptor 69 R metformin Concor 69 hypertrichosis occurred 69 sublingual tablet formulation 69 CYP#A# CYP#D# 69 myelodysplastic myeloproliferative diseases 69 telomerase therapeutic 69 memantine HCl 69 alfa 2a 69 sarcoma melanoma 69 HCV nucleoside polymerase inhibitors 69 hypoxia activated prodrug 69 sapropterin dihydrochloride Tablets 69 SPRYCEL ® 69 NS5b 69 JAK2 Inhibitor 69 candidate CRLX# 69 NicVAX TM 69 phenylalanine ammonia lyase 69 Drug Candidate 69 Aflibercept 69 refractory gout 69 includes TOLAMBA TM 69 sapropterin dihydrochloride Phase 69 product platforms AZX# 69 mg OSMOPREP ® 69 Inc. ProMetic www.prometic.com 69 COPEGUS R 69 OctoPlus licensed 69 TNF Tumor Necrosis Factor 69 XP# XP# 69 vapreotide acetate 69 non thiazolidinedione TZD 69 lenalidomide Revlimid R 69 Phase 2b Trial 69 release capsules FENTORA 69 toenail onychomycosis 69 Romidepsin 69 Peginterferon alfa 2b 69 Metastatic Melanoma 69 include Healive TM 69 herpes zoster shingles 69 Merck Serono Nycomed 69 RON Notch 69 vinorelbine tartrate 69 Prodarsan R 69 infectious diseases autoimmune 69 FDA APPROVES 69 Commences Phase 69 small molecule glucokinase 69 SPL# Gel vaginal microbicide 69 mertansine 69 AQD class 69 atrial fibrillation budiodarone ATI 69 beta 1a 69 Hsp# Inhibitor 69 PDE4 inhibitor 69 sorafenib tablets 69 Kuvan R 69 accumulate preferentially 69 generation Hsp# inhibitor 69 PORxin TM platforms 69 IMiDs R 69 By JENNIFER LEARN 69 investigational oral inhibitor 69 Submits NDA 69 phenyl salicylate methylene blue 69 CCR9 antagonist 69 CHEAP ONLINE PHARMACY LOW 69 AAG KOS 69 interferon gamma 1b 69 ® lenalidomide 69 humanized therapeutic 69 receptor tyrosine kinase inhibitor 69 MT# MEDI 69 oral dihydropyrimidine dehydrogenase DPD 69 mGluR2 positive 69 clinical trials Archexin ® 69 Staphylococcus aureus Immune Globulin 69 CysDisplay R 69 2 inhibitor CYT# 69 IAP inhibitor 69 Xeloda ® 69 bevacizumab Avastin R 69 investigational integrase inhibitor 69 Vitamin D analogue 69 Humanized Anti 69 gastrointestinal disorders ATI 69 FOLOTYN ® 69 allosteric modulator PAM 69 Cytogen marketed 69 phase III isavuconazole 69 Locteron combines 69 product candidate Lpathomab 69 lead Aganocide compound 69 cladribine Cladribine Tablets 69 TLR7 agonist 69 Orally administered 69 R famotidine 68 Novel Oral 68 sunitinib Sutent ® 68 commercializing dermatological products 68 diarrhea fatigue asthenia 68 Provectus Pharmaceuticals specializes 68 Veronate R 68 oral picoplatin 68 indolent follicular non 68 First Patient Dosed 68 Hemispherx flagship products 68 systemic juvenile idiopathic 68 Pegloticase 68 ergot derivatives 68 signal transduction inhibitor 68 evaluating T DM1 68 cardiometabolic diseases Glucophage 68 triciribine phosphate monohydrate 68 selective antagonist 68 Perifosine KRX 68 COLAZAL ® 68 novel histone deacetylase 68 candidate bevirimat PA 68 HIV integrase inhibitors 68 targets HGF FGFR 68 Cerebril TM 68 Bilive R combined 68 treat male hypogonadism 68 metastatic castration resistant 68 Amgen Neulasta R 68 TBC# 68 octreotide acetate 68 BENLYSTA belimumab 68 PEG PAL PEGylated recombinant 68 Peginterferon Alfa 2a 68 Study Evaluating 68 5 FU leucovorin 68 includes VIAtab TM 68 Polymerase Inhibitor 68 liposomal formulation 68 R bisoprolol Euthyrox 68 NS5B polymerase 68 developing ostarine selective 68 Vitrasert ® 68 imatinib Gleevec ® 68 BENLYSTA TM 68 plus Copegus R 68 psoriasis rheumatoid arthritis 68 developing Zerenex TM 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 Phase Ib clinical trials 68 forodesine 68 resistant hormone refractory 68 POSIDUR TM ELADUR TM 68 pharmacogenomic translational research 68 MVA HPV IL2 68 R lenalidomide 68 Launches Generic Version 68 Vicriviroc 68 Pruvel ™ prulifloxacin 68 N acetylgalactosamine 6 68 alfimeprase direct 68 cytidine nucleoside analog 68 antibiotic candidate Ramoplanin 68 molecular imaging radiopharmaceutical 68 HYVISC ® treatment 68 Pivotal Phase III 68 Chronic Hepatitis C 68 allosteric modulator NAM 68 Namenda Memantine HCl 68 hypereosinophilic syndrome 68 HuCAL PLATINUM ® CysDisplay 68 Exelixis compounds 68 development peramivir neuraminidase 68 Achieves Primary Endpoint 68 arsenic trioxide injection 68 Randomized Phase 68 Initiates Clinical Trial 68 metastatic castrate resistant 68 Peginterferon 68 rilonacept Injection 68 TRACON Pharmaceuticals 68 Vidaza ® 68 Personalized Immunotherapy 68 dextromethorphan quinidine 68 intranasal formulation 68 subtype selective NMDA receptor 68 CTAP# Capsules 68 induced macular edema 68 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 68 investigational humanized monoclonal antibody 68 alvespimycin 68 compound INCB# 68 generation purine nucleoside 68 investigational monoclonal antibody 68 cromolyn sodium 68 RhuDex TM 68 CRM# Protein 68 SAR# [002] 68 systemic lupus erythematosus rheumatoid 68 data management Clintrial 68 alpha folate receptor 68 ATRA IV 68 Aeolus Pharmaceuticals Announces 68 dual PPAR peroxisome 68 benzoic acid hyoscyamine sulfate 68 Phase 2a Clinical Trial 68 Agonist MABA program 68 docetaxel Taxotere R 68 panitumumab Vectibix R 68 R sorafenib tablets 68 NOTE POSIDUR ™ 68 ceftazidime 68 SinuNase TM 68 RANK Ligand inhibitor 68 synthetic lipoglycopeptide antibiotic 68 evaluating mipomersen 68 FUSILEV enhances 68 selective androgen receptor modulator 68 markets Testim ® 68 FDA Accepts 68 PATENT FOR 68 relapsed refractory multiple myeloma 68 SUPPRELIN R LA 68 B Anflu R 68 Initiate Phase III 68 DG# compounds targeting 68 Zemiva TM 68 Am J Obstet 68 class mGluR5 inhibitor 68 Letairis ambrisentan 68 ® DS methenamine 68 myelofibrosis polycythemia vera 68 Pafuramidine 68 oral calcitonin licensed 68 relapsed MM 68 infectious diseases autoimmune diseases 68 triggers apoptosis programmed 68 myocardial infarction ventricular fibrillation 68 Sapacitabine 68 tiapamil 68 antibody MAb 68 Granted Orphan Drug 68 TRAIL receptor antibodies 68 selective immunoproteasome inhibitor 68 mGluR5 NAM 68 Cardium Therapeutics TM 68 ADP receptor antagonist 68 TELINTRA 68 non nucleoside HCV 67 Trial Evaluating 67 non porcine pancreatic 67 Files IND 67 COLAZAL R 67 herpetic keratitis 67 individualized cellular immunotherapy 67 PI3K/Akt pathway inhibitor 67 evaluating satraplatin 67 plus prednisone prednisolone 67 estrogen receptor beta agonist 67 Rigel R# 67 Initiates Phase 2b 67 inflammatory PDE 67 Bezielle 67 intravesical infusion therapy 67 thrombin component 67 evaluating tivozanib 67 Ribavirin causes 67 LX# LX# 67 tumor activated prodrug 67 induced mucositis 67 acyclovir Lauriad R 67 Patients Treated With 67 NEBIDO VANTAS SUPPRELIN LA 67 II TRISENOX R 67 2hours #mins #.#secs M 67 HCl PEPCID ® famotidine 67 occlusion PAO 67 CRTH2 67 Copegus ® 67 Phase #b/#a clinical 67 Copegus R 67 YOUR LOCAL ANIMAL SHELTER 67 metastatic colorectal carcinoma 67 Combination REOLYSIN R 67 ® decitabine 67 cortisol synthesis 67 Announces Tentative Approval 67 erlotinib Tarceva R 67 Roche Boniva 67 rash pruritus nausea 67 polyneuropathy HIV DSP 67 R vancomycin hydrochloride 67 stage antibody MT# 67 multi kinase inhibitor 67 CG# oncolytic virus 67 thalidomide Thalomid 67 stage hypoxia activated 67 Long acting beta2 67 selective A2A adenosine receptor 67 systemically administered 67 ELADUR ™ 67 Seliciclib CYC# 67 PRICE GREAT DISCOUNT FREE 67 HCV protease inhibitor 67 histone deacetylase HDAC inhibitor 67 Biogen Genentech 67 Serdaxin ® 67 nasal calcitonin product 67 markets XIFAXAN ® 67 gastro intestinal inflammation 67 Gel repository corticotropin injection 67 HBeAg negative 67 markets HP Acthar 67 apoptosis inducers 67 testing huN# DM1 67 Fast Track Status 67 oral chemotherapeutic agent 67 Interferon alfa 2b 67 5 lipoxygenase activating 67 lexidronam injection PROSTASCINT 67 IgG1 monoclonal antibody 67 docetaxel Taxotere ® 67 containing granisetron 67 selective kinase inhibitor 67 NASH Huntington 67 oral anti arrhythmic 67 AN# topical anti 67 anti botulism antibody 67 investigational oral hepatitis C 67 demonstrated antitumor activity 67 small molecule Hedgehog 67 humanized interleukin 6 67 novel therapeutic antibodies 67 Capsulitis 67 chemosensitizer 67 J Antimicrob Chemother 67 Presents Preclinical 67 cisplatin gemcitabine 67 VISICOL R 67 hormone LHRH antagonist 67 progressive metastatic prostate 67 M# rationally 67 oral dual endothelin 67 carcinoma mCRC 67 R ferumoxytol Injection 67 hyperplasia BPH 67 Kinase Inhibitor 67 Curis collaborator Genentech 67 trastuzumab DM1 T DM1 67 DNA methyltransferase inhibitors 67 pentadentate logo R 67 DepoCyt ® Abelcet ® 67 unresectable recurrent 67 developing ACAPODENE 67 hypoxia selective 67 Oral Fingolimod 67 Genasense ® oblimersen 67 Shigatoxin producing E. coli 67 mitoxantrone plus 67 MAGE A3 ASCI 67 hyperphenylalaninemia HPA due 67 erosive gastritis 67 semi synthetic lipoglycopeptide 67 mecarbil 67 Receives Approvable Letter 67 highly selective inhibitor 67 palonosetron hydrochloride Injection Dacogen 67 Demonstrates Positive 67 dimer protein 67 PEGylated anti 67 including cyclosporine methotrexate 67 Boehringer Ingelheim MedImmune 67 TELINTRA R 67 potent CYP#A# inhibitors 67 RhuDex R 67 candidates Azedra 67 Unigene nasal calcitonin 67 neuro inflammatory disorders 67 Potassium Chloride Sodium Ascorbate 67 registrational Phase 67 non alcoholic steatohepatitis 67 unique alkylating agent 67 Antitumor Activity 67 Factor VIIa 67 gets USFDA nod 67 visilizumab 67 HCV RNA polymerase 67 Genentech Wyeth Pharmaceuticals 67 Commence Phase 67 EVIZON TM squalamine lactate 67 CORT # 67 novel nucleoside analog 67 orally administered synthetic retinoid 67 serine protease inhibitor CU# 67 including HGF ErbB3 67 volociximab 67 albiglutide currently 67 INxin TM 67 highly selective endothelin 67 clinical trials Archexin 67 valtorcitabine 67 commercializing oxidized glutathione 67 Novartis Organon 67 anti amnesic 67 Piperacillin 67 adecatumumab MT# 67 indinavir Crixivan 67 Nicotine Conjugate Vaccine 67 anthracycline taxane 67 non splenectomized 67 interferon alpha IFN 67 octreotide implant 67 Fludara ® 67 bone marrow reticulin deposition 67 Marcus Gronholm BP 67 diabetes irritable bowel 67 selective phosphodiesterase 67 Orally Active 67 Investigational Treatment 67 Disease IBD 67 NYSE PFE Exelon Rivastigmine 67 cancer neuroendocrine tumor 67 INSPIRE Trial Phase III 67 doxepin HCl 67 compound ITMN 67 immunotherapeutic agent 67 vinca alkaloid 67 OTHER THAN PURELY HISTORICAL 67 thiazolides 67 Alfacell proprietary ribonuclease 67 pipeline ImmunoGen collaborators 67 Relapsed Refractory 67 leukemia AML 67 MSCRAMM ® 67 sodium Injection 67 Suppository Hydrocortisone Acetate Rectal 66 neuromuscular spasm 66 known dihydropyrimidine dehydrogenase 66 pan HDAC inhibitor 66 iobenguane 66 CTA# Injection 66 Randomized Double blind 66 Delta opioid receptor 66 XOMA 3AB biodefense 66 acute peptic ulcer 66 secretory phospholipase A2 66 Soft Tissue Sarcoma 66 metastatic ocular 66 PSN# [002] 66 leading oral taxane 66 phosphorylase PNP inhibitor 66 Civacir TM Hepatitis C 66 Aurora kinase inhibitor 66 MTP inhibitor 66 OMP #R# 66 METOZOLV ™ ODT metoclopramide 66 solid tumors ZYBRESTAT 66 EXCHANGE OR 66 Pooled Analysis 66 severe hypercholesterolemia 66 Reports Preclinical Data 66 systemic anaplastic large 66 Silodosin 66 Enrolls First 66 Pivotal Phase 66 targeted anticancer biopharmaceuticals 66 Europe entitled MINDSET 66 R bendamustine hydrochloride 66 please visit http:/www.vandapharma.com 66 balsalazide disodium Capsules 66 CTAP# Injection 66 TRANSDUR ™ 66 selective inverse agonist 66 nucleotide analogue 66 receiving INTRON 66 Horizant ™ 66 ATC ovarian cancer 66 Randomized Double Blind 66 Therapeutic Competitors Companies 66 Relapsed Refractory Multiple Myeloma 66 Chrysalin r rusalatide acetate 66 fibrosis IPF 66 Preclinical Data 66 Primary Hypercholesterolemia 66 PEGylated docetaxel 66 Epivir R 66 Hormone Refractory Prostate Cancer 66 peptidic compound 66 product AMD# 66 ADVANCE ILLUMINATE 66 Elagolix 66 OAB overactive bladder 66 iloprost synthetic compound 66 MAb therapy 66 Oracea TM 66 anti CD3 monoclonal 66 Naive Patients 66 BY WILLA J. 66 Selzentry Celsentri 66 oritavancin semi 66 Kit CD# positive 66 Emtriva emtricitabine 66 Novartis Trileptal 66 PEGINTRON TM 66 Safinamide 66 Ecallantide 66 5 HT2A inverse 66 neuropathic pain spasticity 66 INDIVIDUALLY AND 66 * olmesartan medoxomil 66 tumor xenograft models 66 Receives Orphan Drug 66 anti atherothrombotic 66 antiplatelet compound 66 ® pramlintide acetate 66 Oral Calcitonin 66 Solzira TM 66 Nasdaq MNKD focuses 66 Spectrum Pharmaceuticals Announces 66 NEEDS WHICH MAY CAUSE 66 Maribavir 66 cosmetic cosmeceutical products 66 primary hypercholesterolemia 66 Wafer polifeprosan 66 R loxapine 66 serotonin norepinephrine reuptake inhibitor 66 Hedgehog Pathway Inhibitor 66 #-MILLION DOLLARS [002] 66 Aurora Kinase 66 elotuzumab 66 R pramlintide acetate 66 overactive bladder VANTAS 66 brivanib 66 include Healive 66 forodesine hydrochloride 66 CHEAP ONLINE PHARMACY BEST 66 subsidiaries visit http:/www.apricusbio.com 66 ALS #-# 66 rALLy 66 Releasing Factor 66 DURECT proprietary 66 Retisert ® 66 systemic Phase 1b 66 somatostatin analogue 66 Testosterone MDTS ® 66 positive allosteric modulator 66 IMiDs ® compound 66 Locteron exclusively 66 headache nasopharyngitis 66 acne impetigo 66 vaginal candidiasis 66 Ostabolin C TM 66 S1P antibody 66 5 HT2A serotonin 66 abacavir sulfate lamivudine 66 AP Photo CAR# 66 rheumatoid arthritis thrombocytopenia 66 lead molecular radiotherapeutic 66 ® bortezomib 66 HepeX B TM 66 vomiting anorexia stomatitis 66 orally inhaled migraine 66 Genentech sanofi aventis 66 sulfonylhydrazine class 66 acetylgalactosamine 6 66 overactive bladder AA# 66 cMET 66 TRX1 66 miconazole Lauriad ® 66 oral Janus kinase 66 Emtriva Viread 66 MATERIALLY FROM CURRENT EXPECTATIONS 66 Tibotec Therapeutics division 66 Previously Treated 66 anti PlGF 66 available dual endothelin 66 3TC lamivudine 66 mg q#h 66 SELLERS ABANDONING SHARES OF 66 Zolpimist ™ 66 monoclonal antibody conjugated 66 inhibitor COX 66 Biovail undertakes 66 adenosine injection 66 metabolic alkalosis 66 mesylate tablets approved 66 R tiagabine hydrochloride NUVIGIL 66 Archexin 66 3hours #mins #.#secs M 66 Cobalamin TM mediated 66 IMiDs 66 tramiprosate Alzhemed TM 66 commercializing Loramyc ® 66 gastrointestinal stromal 66 investigational pharmacologically unique 66 peripherally acting 66 cyclobenzaprine hydrochloride extended 66 commercialize Aganocides 66 PROSPECTUS PROXY STATEMENT BECAUSE 66 huC# DM4 66 dyskinesia PD LID 66 CYT# vascular disrupting 66 TAFA# 66 Solazed ™ 66 PROVENGE ® 66 Phase IIb Clinical Trial 66 rxRNA 66 naloxol derivative 66 Zenvia ™ 66 Squibb Genentech 66 R brand eszopiclone 66 Refractory Hodgkin Lymphoma 66 vesicular monoamine transporter 66 1hour #mins #.#secs M 66 J Am Acad 66 polymerase inhibitors 66 candidate SILENOR TM 66 monoclonal antibody IgG1 Mab 66 ARIKACE ™ 66 evaluating intravenous picoplatin 66 Schering Plough Remicade 66 Xyfid TM 66 based pretargeting methods 66 Zemiva ™ 66 proprietary BiTE ® 66 Phase IIa Clinical Trial 66 Cyclooxygenase Inhibiting Nitric Oxide 66 Proquin XR 66 PDX pralatrexate 66 HDAC Inhibitor 66 Pharmos pipeline 66 Therapy RecoveryRx TM 66 interferon alfa 2a 66 Fc fusion protein 66 #HT# 66 % pramoxine HCl 66 LENALIDOMIDE 66 ALTROPANE R 66 KSP inhibitor 66 generation radiolabeled antibody 66 METOZOLV TM ODT metoclopramide 66 Nasdaq AEGR 66 Metab Disord 66 omecamtiv mecarbil formerly 66 romazarit 66 nausea arthralgia insomnia 66 polyglutamate 66 Previously Untreated 66 inhaled formulation 66 Initiated Phase 66 lupus hepatitis C 66 PEG irinotecan 66 alpha 2b 66 Randomized Phase II 66 J Am Coll 66 NEBIDO R 66 GVAX R 66 D aspartate NMDA receptor 66 Tesetaxel 66 USP Tablets MOVIPREP ® 66 Fast Track designations 66 Oral Suspension Oral Suspension 66 includes investigational compounds 66 Oral Solution OSMOPREP 66 R chorionic gonadotropin 66 Talabostat 66 Quinamed R 66 ENMD # 66 Recombinant Human 66 Syncria albiglutide 66 MANAGEMENT 'S CURRENT BELIEFS 66 hepatitis C lupus 66 BiovaxID TM 66 Panzem R NCD 66 idiopathic thrombocytopenic purpura ITP 66 5q MDS 66 treatment naïve genotype 66 ELADUR TM 66 HCV polymerase 66 Phase 2a Trial 66 neutropenia dehydration dyspnea 66 Nasdaq XTLB 66 isolated hypertriglyceridemia 66 itraconazole Sporanox 66 Nuvelo Announces 66 Darinaparsin Zinapar TM 66 5 lipoxygenase inhibitor 66 Aloprim TM allopurinol sodium 66 specific ZFP Nucleases 66 vinca alkaloids 66 Solution XOPENEX HFA 66 aflibercept VEGF Trap 66 5 FU capecitabine 66 Intermezzo ® zolpidem tartrate 66 Preclinical studies suggest 66 BENLYSTA ® 66 ALN TTR 66 AzaSite Xtra 66 SinuNase ™ 66 evaluating bafetinib 66 ENABLE Phase 2 66 treat refractory angina 66 novel synthetic peptide 66 Liprotamase 66 AND ORAL STATEMENTS MADE 66 R DepoCyt 66 diabetes sciatica 66 Offering Pilates 66 anti miRs antisense oligonucleotide 66 humanised monoclonal antibody 66 Through Glycoscience R 66 Soft TADALAFIL SOFT 66 receptor modulators 66 PROCTOCORT ® Suppository Hydrocortisone 66 ALVESCO ® 66 HMG CoA reductase inhibitors 66 AFREZZA ™ 66 WHO TOOK 66 cytomegalovirus immune globulin 66 administered concomitantly 66 develop HBV reactivation 66 Parkinson disease levodopa induced 66 Exherin 65 GW# [003] 65 infliximab monotherapy 65 Cell Mol Physiol 65 Protease Inhibitor 65 By JAMAAL ABDUL 65 minimally symptomatic metastatic castrate 65 AFFECT MICROSEMI 'S 65 human C1 inhibitor 65 Bifunctional Muscarinic Antagonist Beta2 65 IMA# 65 FUSILEV ® 65 accessories autologous 65 Serostim R 65 rubella hepatitis 65 Demonstrates Potent 65 Initiates Clinical 65 Anti PlGF 65 LIMITED AUSTRALIA AMAZON PARTICIPACOES 65 Dapagliflozin 65 somatostatin analog 65 PGL# 65 gastrin analogue TT 65 Vaccine Adjuvant 65 castrate resistant prostate cancer 65 rheumatoid arthritis RA psoriatic 65 ribavirin RBV 65 IN PATIENTS WITH 65 Files Investigational 65 WRX STi +# mins 65 Newly Diagnosed Multiple Myeloma 65 vaccines oncolytic virus 65 DATE HEREOF 65 DDP# 65 BY RYAN ERNST 65 serologically active systemic lupus 65 sulfonylurea glimepiride 65 ASG 5ME dacetuzumab SGN 65 Belimumab 65 dasatinib Sprycel 65 Edurant 65 investigational atypical antipsychotic 65 Omacetaxine 65 Videx Videx EC 65 PMX # heptagonist 65 EDEMA3 trial 65 NEWS RELEASE THE COMPANY 65 Tramiprosate ALZHEMED TM 65 ® ranolazine extended 65 commercialize CorMedix drug 65 RhuDex ® 65 tumors GIST 65 Thiarabine 65 candidate AQ4N 65 migraine headaches neuropathic pain 65 COCA COLA ENTERPRISES INC. 65 Submits IND 65 NASDAQ PPHM clinical 65 Augment TM 65 metformin HCl 65 FULL IMPACT 65 male hypogonadism PRO 65 MPS IVA 65 proteasome inhibitor 65 AZERBAIJAN HIS EXCELLENCY MR 65 neuro inflammatory 65 hormone refractory metastatic prostate 65 events thrombocytopenia neutropenia 65 coronary stent merged 65 included exfoliative dermatitis 65 INVESTMENTS LIMITED CAYMAN ISLANDS 65 PDGFR B 65 CORLUX CORT # 65 nephropathic cystinosis cystinosis 65 LHRH receptor positive 65 TTR amyloidosis 65 Anti Factor VIII 65 JAK1 65 Contrave# 65 recurrent glioblastoma multiforme 65 nano particle tumor suppressor 65 HIV integrase inhibitor 65 Racivir 65 next generation URAT1 65 Epratuzumab